Osaka University

Osaka A team of researchers have discovered that a special toxin producing colon bacillus is causing 70% of colorectal cancer cases involving Japanese patients under the age of 40.

The scientists, primarily from the University of Osaka and the University of Tokyo, are hoping that the latest discovery will ultimately help unlock the mechanisms of contracting a colorectal tumor.

This finding could facilitate the development of preventive measures against this carcinoma.

Controlling the infection route of the bacillus or eradicating the bacteria may prove effective in preventing colorectal cancer at some point in the future, as with dealing with Helicobacter pylori in a quest to combat stomach carcinoma, said Shinichi Yachida, a medical professor at the University of Osaka, of the discovery.

Colorectal cancer is the most common kind of tumor among Japanese, with the number of patients from younger generations increasing as well.

From a global perspective, Japan has an exceptionally high incidence of colorectal carcinoma cases.

Osaka A team of researchers have discovered that a special toxin producing colon bacillus is causing 70% of colorectal cancer cases involving Japanese patients under the age of 40.

The scientists, primarily from the University of Osaka and the University of Tokyo, are hoping that the latest discovery will ultimately help unlock the mechanisms of contracting a colorectal tumor.

This finding could facilitate the development of preventive measures against this carcinoma.

Controlling the infection route of the bacillus or eradicating the bacteria may prove effective in preventing colorectal cancer at some point in the future, as with dealing with Helicobacter pylori in a quest to combat stomach carcinoma, said Shinichi Yachida, a medical professor at the University of Osaka, of the discovery.

Colorectal cancer is the most common kind of tumor among Japanese, with the number of patients from younger generations increasing as well.

From a global perspective, Japan has an exceptionally high incidence of colorectal carcinoma cases.

Osaka A team of researchers has discovered that a special toxin producing colon bacillus is causing 70% of colorectal cancer cases involving Japanese patients under the age of 40.

The scientists, primarily from the University of Osaka and the University of Tokyo, are hoping that the latest discovery will ultimately help unlock the mechanisms of contracting a colorectal tumor.

This finding could facilitate the development of preventive measures against this carcinoma.

Controlling the infection route of the bacillus or eradicating the bacteria may prove effective in preventing colorectal cancer at some point in the future, as with dealing with Helicobacter pylori in a quest to combat stomach carcinoma, said Shinichi Yachida, a medical professor at the University of Osaka, of the discovery.

Colorectal cancer is the most common kind of tumor among Japanese, with the number of patients from younger generations increasing as well.

From a global perspective, Japan has an exceptionally high incidence of colorectal carcinoma cases.

There's another study.

This one is out of Osaka University.

And they looked at a similar specific compound or gene, AP2A1.

It's a protein involved in cellular transport and attachment, and here's what they found.

It's like, how do you best approximate that true tetraploid effect? adult human myocyte, and maybe this is a unique way to get there.

Yeah, this reminds me a bit, there was a study a couple years back by Katsuhiko Hayashi, my guy, germ cell biologist who's at the University of Osaka, and he It was talk about a hack.

Like they were trying to get a male cell that could give rise.

It was essentially the idea of getting a same-sex couple, two males.

So that's the first paper I started with.

And then my co-author, Tetsuya Matsubaya, he's a professor at Osaka University in Japan.

He's been also working on the mental health issues for many years.

So I got to know him and we got started working on the previous paper first on the topic of sunlight on suicide.

Next up, a vibration-driven catalyst for carbon dioxide conversion.

University of Osaka engineers created a barium titanate catalyst coated with a metal organic framework that concentrates carbon dioxide near copper reaction sites.

Ultrasonic vibration activates the material, achieving nearly five-fold higher conversion rates to carbon monoxide.

The design exploits mechanical energy to drive the reaction.

There's nowhere in nature that happens.

What's very interesting about molecular hydrogen is it was first studied at the University of Osaka, Japan in 2007, um, in an effort to save divers from the bends, um, utilizing adjunctive therapy to HBOT.

And what they discovered, and they published their paper in 2010 in Nature Magazine, and since then almost 3,000 studies have ensued, is that molecular hydrogen- Hydrogen is actually an inherent essential nutrient.

There are two kinds of nutrients, nutrients that feed us, right? Like fruits, vegetables, things like that, and nutrients that our body cannot create and whose only job is to push biochemical reactions in the body, like vitamin C.

On the last Authors at Drucker, we featured Pierre-Yves Dons.

Pierre is a professor of business history at Osaka University's Graduate School of Economics.

He's the author of a book called The Making of a Status Symbol, A Business History of Rolex.

If you missed that conversation, I would highly encourage you to go to our YouTube channel or the website and check out the replay.

Osaka startup hopes disposable endoscope eases patients' burden.

Osaka-- A University of Osaka-affiliated company has made a disposable endoscope that is a cost-effective, straightforward alternative to barium X-ray examinations and existing viewing tube tests for stomach cancer.

Endoluminal Solutions Incorporated hopes to not only ease healthcare workers' responsibilities by eliminating the arduous processes of cleaning and recycling the viewing tube, but also lessening the patient's burden.

The Osaka-headquartered company announced on July 1st that clinical application of its endoscope specifically intended for stomach cancer examinations is within reach.